Abbott Laboratories

ABT: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|!kLOCK|NS!>BLOCK|<PH@Dh

Abbott Labs: Acquisition of Exact Sciences to Beef Up Diagnostics

Abbott announced its planned acquisition of Exact Sciences, which makes several oncology-focused tests, for roughly $21 billion, or $105 per share.

Sponsor Center